Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Lee

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Frontiers in Public Health|March 25, 2024
Effectively communicating with local policymakers: a randomized trial of policy brief dissemination to address obesityElizabeth A Dodson, Renee G Parks, Rebekah R Jacob, et al.
Oncotarget|November 9, 2017
The role of EGFR double minutes in modulating the response of malignant gliomas to radiotherapyYi-Hong Zhou, Yumay Chen, Yuanjie Hu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 23, 2019
MicroRNA-135a-3p regulates angiogenesis and tissue repair by targeting p38 signaling in endothelial cellsBasak Icli, Winona Wu, Denizhan Ozdemir, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 17, 2019
MicroRNA-615-5p Regulates Angiogenesis and Tissue Repair by Targeting AKT/eNOS (Protein Kinase B/Endothelial Nitric Oxide Synthase) Signaling in Endothelial CellsBasak Icli, Winona Wu, Denizhan Ozdemir, et al.
Cancer Cell|July 7, 2015
PF-06463922, an ALK/ROS1 Inhibitor, Overcomes Resistance to First and Second Generation ALK Inhibitors in Preclinical ModelsHelen Y Zou, Luc Friboulet, David P Kodack, et al.
Cancer Cell|September 14, 2021
Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitorKevin Freeman-Cook, Robert L Hoffman, Nichol Miller, et al.
Nature Genetics|March 29, 2013
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancerPaul D P Pharoah, Ya-Yu Tsai, Susan J Ramus, et al.
Plos Pathogens|July 29, 2016
Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and BeyondWesley C Van Voorhis, John H Adams, Roberto Adelfio, et al.
Nature Communications|March 29, 2013
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31Jennifer Permuth-Wey, Kate Lawrenson, Howard C Shen, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Frontiers in Public Health|March 25, 2024
Effectively communicating with local policymakers: a randomized trial of policy brief dissemination to address obesityElizabeth A Dodson, Renee G Parks, Rebekah R Jacob, et al.
Oncotarget|November 9, 2017
The role of EGFR double minutes in modulating the response of malignant gliomas to radiotherapyYi-Hong Zhou, Yumay Chen, Yuanjie Hu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 23, 2019
MicroRNA-135a-3p regulates angiogenesis and tissue repair by targeting p38 signaling in endothelial cellsBasak Icli, Winona Wu, Denizhan Ozdemir, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 17, 2019
MicroRNA-615-5p Regulates Angiogenesis and Tissue Repair by Targeting AKT/eNOS (Protein Kinase B/Endothelial Nitric Oxide Synthase) Signaling in Endothelial CellsBasak Icli, Winona Wu, Denizhan Ozdemir, et al.
Cancer Cell|July 7, 2015
PF-06463922, an ALK/ROS1 Inhibitor, Overcomes Resistance to First and Second Generation ALK Inhibitors in Preclinical ModelsHelen Y Zou, Luc Friboulet, David P Kodack, et al.
Cancer Cell|September 14, 2021
Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitorKevin Freeman-Cook, Robert L Hoffman, Nichol Miller, et al.
Nature Genetics|March 29, 2013
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancerPaul D P Pharoah, Ya-Yu Tsai, Susan J Ramus, et al.
Plos Pathogens|July 29, 2016
Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and BeyondWesley C Van Voorhis, John H Adams, Roberto Adelfio, et al.
Nature Communications|March 29, 2013
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31Jennifer Permuth-Wey, Kate Lawrenson, Howard C Shen, et al.
Pageof 6